Stocks and Investing
Stocks and Investing
Wed, August 14, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Whitney Ijem Maintained (TSHA) at Strong Buy with Decreased Target to $6 on, Aug 14th, 2024
Whitney Ijem of Canaccord Genuity, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy with Decreased Target from $7 to $6 on, Aug 14th, 2024.
Whitney has made no other calls on TSHA in the last 4 months.
There are 7 other peers that have a rating on TSHA. Out of the 7 peers that are also analyzing TSHA, 0 agree with Whitney's Rating of Hold.
These are the ratings of the 7 analyists that currently disagree with Whitney
- Geulah Livshits of "Chardan Capital" Maintained at Strong Buy and Held Target at $7 on, Tuesday, August 13th, 2024
- Gil Blum of "Needham" Maintained at Strong Buy with Decreased Target to $6 on, Monday, August 12th, 2024
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $7 on, Monday, July 1st, 2024
- Keith Tapper of "BMO Capital" Initiated at Buy and Held Target at $5 on, Thursday, June 27th, 2024
- Kristen Kluska of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $7 on, Thursday, June 20th, 2024
- Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $5 on, Thursday, June 20th, 2024
- Eun Yang of "Jefferies" Initiated at Strong Buy with Increased Target to $8 on, Tuesday, May 14th, 2024
Contributing Sources